灵洋品牌怎么样 申请店铺

我要投票 灵洋在医疗器械行业中的票数:621 更新时间:2026-01-19
灵洋是哪个国家的品牌?「灵洋」是 浙江灵洋医疗器械有限公司 旗下著名品牌。该品牌发源于浙江省台州市,由创始人胡军飞在2000-12-25期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力灵洋品牌出海!将品牌入驻外推网,定制灵洋品牌推广信息,可以显著提高灵洋产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

灵洋怎么样

浙江灵洋医疗器械有限公司,坐落在临海市的西部开发区。公司的前身是成立于1987年的临海市医疗器械厂,创办之初即定位于一次性医疗器械的专业制造。

公司总占地面积80亩,总建筑面积5.5万平方米,其中10万级洁净厂房1.6万平方米。现有员工760人,管理人员91人,研发人员39人。

2012年以来,公司结合“医疗器械质量管理规范”的要求,在生产自动化方面加大投入,投资2000多万元,对现有洁净车间进行改造,引进各零部件自动组装机、包装线等国内外全自动生产线,以自动化设备替代手工操作,大大提高生产效率;同时具备全套的检测仪器,为企业的发展提供质量保障。

历年来,公司本着“锐意进取,开拓创新,永无止境”的企业精神,围绕“分秒求创新 点滴显真情”的价值观,专注于科技型、人性化产品的创新活动。通过ISO9001质量体系,ISO14001环境体系和OHSAS18001体系认证,针对每个产品每道工序,公司制定产品生产工艺流程与工艺指导文件,共建立100多个控制文件,生产过程严格执行工艺文件规定,每道工艺经过验证评价后使用。按各产品质量要求制定进货检验、过程控制和出厂检验等规范,并设立90多个生产过程质量控制点。

经过多年的创新与发展,现已成为行业内主导生产一次性输液器类、注射器类和氧疗护理类三大系列产品的企业。先后申请获得16项发明专利和实用新型专利。自主开发组合钢针型输液器、一次性使用低阻力注射器、一次性使用精密过滤输液器、一次性使用组合吸痰管等专利产品。低阻力注射器、组合吸痰管、离子膜精密过滤输液器,不断的技术创新和产品开发成就企业一个又一个亮点,为企业的发展奠定基础。

优质的产品,良好的企业形象,促进公司不断持续地发展,现在灵洋公司集研发、生产、销售于一体,在各地设有几十个分公司和办事处,销售网络覆盖全国。

“灵洋”是一支具有高度凝聚力、创新力和战斗力的团队,正以“海纳百川”的气魄热忱的欢迎四方人才的加盟;以“同甘苦、共荣辱”的协作精神推动灵洋公司向国际化企业集团昂首奋进。


Zhejiang Lingyang Medical Equipment Co., Ltd. is located in the Western Development Zone of Linhai City. The predecessor of the company is Linhai medical device factory, which was founded in 1987. At the beginning of its establishment, it was located in the professional manufacturing of disposable medical devices. The company covers an area of 80 mu, with a total construction area of 55000 square meters, including 16000 square meters of 100000 level clean workshop. At present, there are 760 employees, 91 management personnel and 39 R & D personnel. Since 2012, the company has increased investment in production automation in accordance with the requirements of "medical device quality management standard", invested more than 20 million yuan, renovated the existing clean workshop, introduced automatic assembly machines, packaging lines and other fully automatic production lines at home and abroad, replaced manual operation with automatic equipment, greatly improving production efficiency; at the same time, it has a full set of detectors To provide quality assurance for the development of enterprises. Over the years, based on the enterprise spirit of "forge ahead, develop and innovate, never-ending", focusing on the value of "seeking innovation every minute to show the truth", the company has focused on the innovation activities of technology-based and humanized products. Through ISO9001 quality system, ISO14001 environmental system and OHSAS18001 system certification, the company has developed product production process and process guidance documents for each process of each product, and established more than 100 control documents in total. The production process strictly complies with the requirements of process documents, and each process is used after verification and evaluation. Formulate incoming inspection, process control and delivery inspection specifications according to product quality requirements, and set up more than 90 production process quality control points. After years of innovation and development, it has become a leading manufacturer of three series of products in the industry: disposable infusion sets, syringes and oxygen therapy nursing. It has applied for 16 invention patents and utility model patents. Independent development of combination of steel needle infusion set, disposable low resistance syringe, disposable precision filter infusion set, disposable combination suction tube and other patented products. Low resistance syringe, combined suction tube, ion-exchange membrane precision filtration infusion set, continuous technological innovation and product development have made the enterprise one by one bright spot, laying the foundation for the development of the enterprise. High quality products and good corporate image promote the continuous development of the company. Now Lingyang company integrates R & D, production and sales. It has dozens of branches and offices all over the country, with sales network covering the whole country. "Lingyang" is a team with high cohesion, innovation and combat effectiveness. With the spirit of "embracing all rivers and seas", we warmly welcome the talents from all over the world to join us. With the spirit of "sharing weal and woe, sharing honor and Disgrace", we are pushing Lingyang company forward to an international enterprise group.

本文链接: https://brand.waitui.com/c74a5fb5e.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

今年春运民航旅客运输量有望创历史新高

从民航局了解到,春运期间,传统的返乡流、探亲流、学生流与旺盛的旅游度假客流相互叠加,航空出行需求将进一步释放。据预测,今年春运全国民航旅客运输量有望达到9500万人次,日均238万人次,同比增长约5.3%。春节假期前后预计会形成两轮客流高峰。特别是今年春节较晚,节后学生和社会人员返程客流更加集中,单日客流高峰有望达到260万人次。从航空公司预先飞行计划情况看,今年春运全国民航预计保障航班78万班,日均19400班,同比增长5%。(央视新闻)

2小时前

北汽蓝谷:预计2025年净亏损43.5亿元—46.5亿元

36氪获悉,北汽蓝谷公告,公司预计2025年年度归属于上市公司股东的净亏损为43.5亿元到46.5亿元;预计2025年年度归属于上市公司股东的扣除非经常性损益后的净亏损46.5亿元到49.5亿元。

2小时前

Chris Hohn旗下对冲基金去年大赚189亿美元,打破城堡投资纪录

Chris Hohn去年打破对冲基金的盈利纪录,而股市上涨和全球市场波动加剧帮助该行业累计实现盈利5430亿美元,同样创下历史新高。根据金融公司Edmond de Rothschild估计,Hohn麾下专注于股票投资的TCI Fund Management去年获利189亿美元。这超过了肯·格里芬旗下城堡投资2022年创下的纪录,也超越了2007年次贷危机期间约翰·保尔森大肆做空斩获的150亿美元——后被誉为“史上最伟大的交易”。(财联社)

2小时前

盛景微:2025年净利润同比预降34.53%—56.35%

36氪获悉,盛景微公告,预计2025年实现归属于母公司所有者的净利润1000万元到1500万元,同比减少34.53%到56.35%。报告期内,公司主要产品销量稳定,与上年基本持平,但营收、利润下降,主要原因是民爆行业市场需求不振、产能过剩及行业内竞争激烈,民爆行业经济运行持续下行的态势导致主要产品均价下降。

2小时前

莱斯信息:2025年净利润同比预降53.5%—69%

36氪获悉,莱斯信息公告,预计公司2025年实现归属于母公司所有者的净利润为4000万元到6000万元,同比减少53.5%到69%。报告期内,公司业绩较上年同期下降的主要原因系本年城市道路交通管理领域收入规模较去年同期下降较多。

2小时前

本页详细列出关于灵洋的品牌信息,含品牌所属公司介绍,灵洋所处行业的品牌地位及优势。
咨询